J. Loureiro, M. Coelho, S. Rocha, Maria do Carmo Pereira
{"title":"抑制β淀粉样蛋白聚集的潜在治疗肽和载体的设计","authors":"J. Loureiro, M. Coelho, S. Rocha, Maria do Carmo Pereira","doi":"10.1109/ENBENG.2012.6331364","DOIUrl":null,"url":null,"abstract":"The conformational changes and aggregation of amyloid β peptide (Aβ) are associated to Alzheimer's disease (AD). The aim of this work is to study the structure and fibril assembly of Aβ in the presence of charged and nonionic amphiphiles, and β-sheet breaker peptides/conjugates. It is expected that these molecules will inhibit Aβ aggregation. Liposome systems will be developed as carriers for these peptide conjugates to cross the brain blood barrier (BBB).","PeriodicalId":399131,"journal":{"name":"2012 IEEE 2nd Portuguese Meeting in Bioengineering (ENBENG)","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2012-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Design of potential therapeutic peptides and carriers to inhibit amyloid β peptide aggregation\",\"authors\":\"J. Loureiro, M. Coelho, S. Rocha, Maria do Carmo Pereira\",\"doi\":\"10.1109/ENBENG.2012.6331364\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The conformational changes and aggregation of amyloid β peptide (Aβ) are associated to Alzheimer's disease (AD). The aim of this work is to study the structure and fibril assembly of Aβ in the presence of charged and nonionic amphiphiles, and β-sheet breaker peptides/conjugates. It is expected that these molecules will inhibit Aβ aggregation. Liposome systems will be developed as carriers for these peptide conjugates to cross the brain blood barrier (BBB).\",\"PeriodicalId\":399131,\"journal\":{\"name\":\"2012 IEEE 2nd Portuguese Meeting in Bioengineering (ENBENG)\",\"volume\":\"2 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-10-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2012 IEEE 2nd Portuguese Meeting in Bioengineering (ENBENG)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/ENBENG.2012.6331364\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2012 IEEE 2nd Portuguese Meeting in Bioengineering (ENBENG)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ENBENG.2012.6331364","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Design of potential therapeutic peptides and carriers to inhibit amyloid β peptide aggregation
The conformational changes and aggregation of amyloid β peptide (Aβ) are associated to Alzheimer's disease (AD). The aim of this work is to study the structure and fibril assembly of Aβ in the presence of charged and nonionic amphiphiles, and β-sheet breaker peptides/conjugates. It is expected that these molecules will inhibit Aβ aggregation. Liposome systems will be developed as carriers for these peptide conjugates to cross the brain blood barrier (BBB).